glp-1 and gip for weight loss Potential Use of GIP/GLP-1 Receptor Agonists Respiratory Disorders: Where Are We at? Medical Weight Loss GLP-1/GIP |

Their capacity to improve hormonal profiles presents an additional therapeutic advantage for men experiencing infertility linked to obesity

Tirzepatide is a dual GIP and GLP-1 receptor agonist, and both receptor systems have characteristics that influence how the body responds to varying drug levels

Current GLP-1 use by age is reported in KFF's writeup of the poll

What happens if you stop using GLP-1 medication

ECL3 appears to play a role in ligand and/or ECD recognition in GCGR (Koth et al., 2012)

Over the course of this interview, she shares how she evaluates peptides, why gut function is foundational to hormone optimization, how she approaches GLP1 microdosing, and what she watches for in long-term care